Catalyst Wire Dossier Catalyst Wire Dossier

GSK221149

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GSK221149, covering 2012-03-19 to 2017-06-15. Get the full timeline:

Most recent: Clinical Trial Update: A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole [Phase 1]

See pricing